FDA Inspection
University Of Virginia Health SystemUniversity Of Virginia Health System – FDA Inspection, Jun 12, 2026
Record Details
This FDA Inspection record concerns University Of Virginia Health System, with an inspection on June 12, 2026, issued by the Baltimore District Office, covering biologics.
View Company Profile
ID · eca65aae-dc20-4471-9f45-19293bc6b3e9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1321822
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)(6)Methods of component preparation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of University Of Virginia Health System
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2024 | VAI | Baltimore District Office | Blood and Blood Products |
| May 13, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 26, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 23, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 15, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for University Of Virginia Health System
- FDA Inspection 1249455 - 2024-09-12
- FDA Inspection 1170707 - 2022-05-13
- FDA Inspection 1094453 - 2019-04-26
- FDA Inspection 1020992 - 2017-06-23
- FDA Inspection 774771 - 2012-03-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.